Design Therapeutics, Inc.
DSGN
$3.50
-$0.02-0.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.72M | -13.65M | -13.04M | -11.79M | -11.11M |
| Total Depreciation and Amortization | 159.00K | 149.00K | 153.00K | 151.00K | 143.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.48M | 2.03M | 1.66M | 1.73M | 1.46M |
| Change in Net Operating Assets | -1.71M | 1.61M | 1.68M | -1.35M | -2.93M |
| Cash from Operations | -16.79M | -9.86M | -9.55M | -11.26M | -12.44M |
| Capital Expenditure | -72.00K | 0.00 | 16.00K | -161.00K | -195.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.94M | 1.83M | -5.84M | 27.49M | 20.81M |
| Cash from Investing | 7.87M | 1.83M | -5.83M | 27.33M | 20.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.00K | 263.00K | 1.00K | 229.00K | 20.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.00K | 263.00K | 1.00K | 229.00K | 20.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.90M | -7.77M | -15.37M | 16.30M | 8.20M |